These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 17954178

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serial soluble CD30 measurements as a predictor of kidney graft outcome.
    Halim MA, Al-Otaibi T, Al-Muzairai I, Mansour M, Tawab KA, Awadain WH, Balaha MA, Said T, Nair P, Nampoory MR.
    Transplant Proc; 2010 Apr; 42(3):801-3. PubMed ID: 20430176
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients.
    Wang D, Wu WZ, Chen JH, Yang SL, Wang QH, Zeng ZX, Tan JM.
    Transpl Immunol; 2010 Feb; 22(3-4):115-20. PubMed ID: 20036333
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection?
    Azarpira N, Aghdaie MH, Malekpour Z.
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):31-6. PubMed ID: 20061689
    [Abstract] [Full Text] [Related]

  • 11. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
    Matinlauri I, Höckerstedt K, Isoniemi H.
    Transplant Proc; 2006 Dec; 38(10):3601-4. PubMed ID: 17175343
    [Abstract] [Full Text] [Related]

  • 12. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
    Kim MS, Kim HJ, Kim SI, Ahn HJ, Ju MK, Kim HJ, Jeon KO, Kim YS.
    Transplantation; 2006 Dec 27; 82(12):1602-5. PubMed ID: 17198243
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Soluble CD30 as a prognostic factor for outcome following renal transplantation.
    Platt RE, Wu KS, Poole K, Newstead CG, Clark B.
    J Clin Pathol; 2009 Jul 27; 62(7):662-3. PubMed ID: 19561239
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pretransplant soluble CD30 is a better predictor of posttransplant development of donor-specific antibodies and acute vascular rejection than panel reactive antibodies.
    Vaidya S, Partlow D, Barnes T, Gugliuzza K.
    Transplantation; 2006 Dec 27; 82(12):1606-9. PubMed ID: 17198244
    [Abstract] [Full Text] [Related]

  • 18. Does pretransplant soluble CD30 serum concentration affect deceased-donor kidney graft function 3 years after transplantation?
    Kovac J, Arnol M, Vidan-Jeras B, Bren AF, Kandus A.
    Transplant Proc; 2008 Jun 27; 40(5):1357-61. PubMed ID: 18589105
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.